KG
Kelsey Goodwin Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
52%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $115 |
1%
upside
| 1 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $120 |
19%
upside
| 1 | +91% |
0
%
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $14 |
13%
upside
| 1 | +34% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $30 |
109%
upside
| 1 | -21% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $11 |
27%
downside
| 2 | +111% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $70 |
14%
upside
| 1 | +60% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $8 |
225%
upside
| 1 | -21% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $24 |
287%
upside
| 1 | +21% |
0
%
| 7 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $22 |
63%
upside
| 1 | +66% |
0
%
| 7 Jan ‘26 1 month ago |
|